PubMed

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.

Koïtka A, Cao Z, Koh P, Watson AM, Sourris KC, Loufrani L, Soro-Paavonen A, Walther T, Woollard KJ, Jandeleit-Dahm KA, Cooper ME, Allen TJ.

Diabetologia. 2009 Dec 3. [Epub ahead of print]PMID: 19957160 [PubMed - as supplied by publisher]Related articles

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

Watson AM, Li J, Schumacher C, de Gasparo M, Feng B, Thomas MC, Allen TJ, Cooper ME, Jandeleit-Dahm KA.

Diabetologia. 2009 Oct 28. [Epub ahead of print]PMID: 19862499 [PubMed - as supplied by publisher]Related articles

Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis.

Pham Y, Tu Y, Wu T, Allen TJ, Calkin AC, Watson AM, Li J, Jandeleit-Dahm KA, Toh BH, Cao Z, Cooper ME, Chai Z.

Diabetologia. 2009 Oct 22. [Epub ahead of print]PMID: 19847393 [PubMed - as supplied by publisher]Related articles

Direct antiatherosclerotic effects of PPAR agonists.

Jandeleit-Dahm KA, Calkin A, Tikellis C, Thomas M.

Curr Opin Lipidol. 2009 Feb;20(1):24-9. Review.PMID: 19133407 [PubMed - indexed for MEDLINE]Related articles

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation.

Calkin AC, Giunti S, Sheehy KJ, Chew C, Boolell V, Rajaram YS, Cooper ME, Jandeleit-Dahm KA.

Diabetologia. 2008 Sep;51(9):1731-40. Epub 2008 Jul 2.PMID: 18594792 [PubMed - indexed for MEDLINE]Related articles

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.

Soro-Paavonen A, Watson AM, Li J, Paavonen K, Koitka A, Calkin AC, Barit D, Coughlan MT, Drew BG, Lancaster GI, Thomas M, Forbes JM, Nawroth PP, Bierhaus A, Cooper ME, Jandeleit-Dahm KA.

Diabetes. 2008 Sep;57(9):2461-9. Epub 2008 May 28.PMID: 18511846 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules.

Tikellis C, Jandeleit-Dahm KA, Sheehy K, Murphy A, Chin-Dusting J, Kling D, Sebokova E, Cooper ME, Mizrahi J, Woollard KJ.

Atherosclerosis. 2008 Jul;199(1):55-64. Epub 2008 Feb 21.PMID: 18093596 [PubMed - indexed for MEDLINE]Related articles

PPARs and diabetes-associated atherosclerosis.

Calkin AC, Jandeleit-Dahm KA, Sebekova E, Allen TJ, Mizrahi J, Cooper ME, Tikellis C.

Curr Pharm Des. 2007;13(26):2736-41. Review.PMID: 17897018 [PubMed - indexed for MEDLINE]Related articles

Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB.

Circulation. 2007 Apr 24;115(16):2178-87. Epub 2007 Apr 9.PMID: 17420349 [PubMed - indexed for MEDLINE]Related articlesFree article

Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouse.

Calkin AC, Allen TJ, Lassila M, Tikellis C, Jandeleit-Dahm KA, Thomas MC.

Atherosclerosis. 2007 Nov;195(1):17-22. Epub 2007 Jan 9.PMID: 17214990 [PubMed - indexed for MEDLINE]Related articles

PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.

Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC.

Nephrol Dial Transplant. 2006 Sep;21(9):2399-405. Epub 2006 May 23.PMID: 16720596 [PubMed - indexed for MEDLINE]Related articlesFree article

Dual ACE/NEP inhibitors - more than playing the ACE card.

Jandeleit-Dahm KA.

J Hum Hypertens. 2006 Jul;20(7):478-81. Epub 2006 Mar 16. No abstract available. PMID: 16543904 [PubMed - indexed for MEDLINE]Related articles

Preventing atherosclerosis with angiotensin-converting enzyme inhibitors: emphasis on diabetic atherosclerosis.

Allen TJ, Jandeleit-Dahm KA.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):503-12. Review.PMID: 16503870 [PubMed - indexed for MEDLINE]Related articles

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation.

Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ.

Diabetologia. 2006 Apr;49(4):766-74. Epub 2006 Feb 4.PMID: 16463048 [PubMed - indexed for MEDLINE]Related articles

Lipids and diabetic renal disease.

Cooper ME, Jandeleit-Dahm KA.

Curr Diab Rep. 2005 Dec;5(6):445-8. Review.PMID: 16316596 [PubMed - indexed for MEDLINE]Related articles

Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies.

Jandeleit-Dahm KA, Lassila M, Allen TJ.

Ann N Y Acad Sci. 2005 Jun;1043:759-66. Review.PMID: 16037303 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects.

Calkin AC, Forbes JM, Smith CM, Lassila M, Cooper ME, Jandeleit-Dahm KA, Allen TJ.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1903-9. Epub 2005 Jul 14.PMID: 16020748 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced-glycation end products in insulin-resistant states.

Soldatos G, Cooper ME, Jandeleit-Dahm KA.

Curr Hypertens Rep. 2005 Apr;7(2):96-102. Review.PMID: 15748532 [PubMed - indexed for MEDLINE]Related articles

Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes.

Jandeleit-Dahm KA, Tikellis C, Reid CM, Johnston CI, Cooper ME.

J Hypertens. 2005 Mar;23(3):463-73. Review.PMID: 15716683 [PubMed - indexed for MEDLINE]Related articles

Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.

J Am Soc Nephrol. 2004 Aug;15(8):2125-38.PMID: 15284298 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

Forbes JM, Yee LT, Thallas V, Lassila M, Candido R, Jandeleit-Dahm KA, Thomas MC, Burns WC, Deemer EK, Thorpe SR, Cooper ME, Allen TJ.

Diabetes. 2004 Jul;53(7):1813-23. Erratum in: Diabetes. 2006 Mar;55(3):862. Thorpe, Susan M [corrected to Thorpe, Susan R]. PMID: 15220206 [PubMed - indexed for MEDLINE]Related articlesFree article

Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.

Candido R, Allen TJ, Lassila M, Cao Z, Thallas V, Cooper ME, Jandeleit-Dahm KA.

Circulation. 2004 Mar 30;109(12):1536-42. Epub 2004 Mar 15.PMID: 15023892 [PubMed - indexed for MEDLINE]Related articlesFree article

Imatinib attenuates diabetes-associated atherosclerosis.

Lassila M, Allen TJ, Cao Z, Thallas V, Jandeleit-Dahm KA, Candido R, Cooper ME.

Arterioscler Thromb Vasc Biol. 2004 May;24(5):935-42. Epub 2004 Feb 26.PMID: 14988091 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.

Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ.

Circulation. 2002 Jul 9;106(2):246-53.PMID: 12105166 [PubMed - indexed for MEDLINE]Related articlesFree article